• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Economy Socio Economic

FDA approval of the Covid-19 vaccine could drive vaccinations in US

Chidinma Anyalewechi by Chidinma Anyalewechi
August 10, 2021
in Socio Economic
Covid-19: AstraZeneca vaccine gets huge boost, produces immune response in elderly, Vaccine, COVID-19: Russia to roll out vaccine in September ahead of the West 

Covid-19: AstraZeneca vaccine

Share on FacebookShare on TwitterShare on Linkedin

Pfizer’s Covid-19 vaccine is currently only authorized for emergency use in the United States, however, its full approval by the US Food and Drug Administration could happen within weeks and this could alter the course of the pandemic in several ways.

First, the full approval, by the FDA, of a Covid-19 vaccine would persuade more people to get vaccinated and more than 30% of the eligible population in the United States still hasn’t gotten vaccinated.

This is as a result of insufficient data to convince some Americans that the vaccines are not dangerous.

RelatedStories

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 

September 26, 2024
Covid-19: AstraZeneca vaccine gets huge boost, produces immune response in elderly, Vaccine, COVID-19: Russia to roll out vaccine in September ahead of the West 

AstraZenaca to launch new COVID-19 prevention drug amid global withdrawal of vaccine 

May 17, 2024

For a vaccine to qualify for emergency use authorization, their makers have to submit about three months of clinical trial data which includes at least 2 months of safety data on fully vaccinated participants, since most vaccine side effects occur 2-3 months after the vaccination.

The full FDA approval of a vaccine requires much more data, including safety and efficacy data generated in the real-world, outside of a clinical trial. The CDC has been tracking real-world data on the vaccines and more than 165 million people in the US are now vaccinated against the virus and this extra data may help convince more people that the vaccines are not dangerous.

An associate professor in the division of infectious disease epidemiology at Johns Hopkins Bloomberg School of Public Health, Dr David Dowdy, has said that the approval by the FDA will go a long way to reassure some people about the safety of the vaccine. He said, “For some, getting a full FDA approval will help allay that fear. Even if it’s just a relatively small number of people. Every little bit helps against this virus”.

Dr. Paul Offit, a prominent member of the FDA’s vaccine advisory committee and director of the Vaccine Education Center at the Children’s Hospital of Philadelphia, says that the agency is “working around the clock” on the approval of the Covid-19 vaccine.

According to Dr. Offit, the approval should not really matter since a large part of the population have already been vaccinated, which tells you that this is not experimental, however, he agrees that it does matter to some people who are hesitant because they are unsure on whether to view the vaccines as a licensed product or just approved through the EUA and happen to have more faith in the FDA.

“I think from the standpoint of the public, it really shouldn’t matter,” Offit said. “It’s been given to half of the American population. We have more than 300 million doses out there. This is far from experimental. We have a tremendous safety and efficacy portfolio on these vaccines — I mean, it’s more than most licensed products that are out there now.”

“I think they realize that at least there’s a psychological issue with how these vaccines are viewed, in terms of whether they’re a licensed product or just approved through EUA,” Offit added.


Follow us for Breaking News and Market Intelligence.
Tags: Covid-19 vaccineDr. Paul OffitPfizerUS Food and Drug Administration
Chidinma Anyalewechi

Chidinma Anyalewechi

For further inquiries about this article, contact: Email: chidinma.anyalewechi@nairametrics.com LinkedIn: linkedin.com/in/chidinma-anyalewechi-a323ab173/

Related Posts

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 
Health

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 

September 26, 2024
Covid-19: AstraZeneca vaccine gets huge boost, produces immune response in elderly, Vaccine, COVID-19: Russia to roll out vaccine in September ahead of the West 
Health

AstraZenaca to launch new COVID-19 prevention drug amid global withdrawal of vaccine 

May 17, 2024
Pfizer
Company News

Pfizer shares plunge 7% as 2024 revenue forecast falls below consensus estimates 

December 13, 2023
Pfizer loses $10 billion slice from obesity drug market as it discontinues its weight loss pill 
Health

Pfizer loses $10 billion slice from obesity drug market as it discontinues its weight loss pill 

December 5, 2023
Moderna
Health

Moderna Shares fall by 6.5% after reported loss in sales, production of Covid 19 vaccine

November 3, 2023
FEC approves process for indigenisation of vaccine production
Socio Economic

FEC approves process for indigenisation of vaccine production in Nigeria

September 15, 2022
Next Post
Strong performance from Stanbic IBTC, despite weak retail banking position

Stanbic IBTC PMI highlights six months of business expansion

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank
Zenth Bank








DUNS

Recent News

  • Tinubu seeks swift action on ECOWAS Standby Force as insecurity escalates in West Africa 
  • Global oil price may surge past $150 per barrel as Iran’s parliament approves closure of Strait of Hormuz 
  • President Trump’s visa restrictions threaten 16 U.S. colleges depedent on international students 

Follow us on social media:

Recent News

Tinubu seeks swift action on ECOWAS Standby Force as insecurity escalates in West Africa 

Tinubu seeks swift action on ECOWAS Standby Force as insecurity escalates in West Africa 

June 22, 2025
Latest crude oil price drop threatens Nigeria’s revenue and naira stability 

Global oil price may surge past $150 per barrel as Iran’s parliament approves closure of Strait of Hormuz 

June 22, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics